浏览其他金融产品
Novartis AG
NVS重点摘要
最后更新: 2026-07-06- •诺华已同意以高达15亿美元(预付款+里程碑付款)的价格收购英国公司Myricx Bio,交易预计于2026年下半年完成,已获约束性协议。
- •该交易目标是NMTi-ADC技术,巩固了抗体偶联药物作为制药行业竞争最激烈的创新前沿地位。
- •收购方(NVS)可能面临短期抛售压力,因投资者需评估里程碑风险;此前类似交易曾出现温和的初期下跌。
- •ADC领域的生物技术同行因潜在收购概率提高和估值倍数上行压力而受益。
- •此次英国生物技术公司的成功退出验证了英国精准肿瘤学生态系统的价值,并为伦敦上市的生命科学公司及欧洲医疗保健指数提供了温和的积极信号。
价格与市场结构
交易制度状态
术语表
关键上市股票与 CFD 词汇,每个一句 —— 让页面对读者和 AI 引擎都清晰无歧义。
| 股票差价合约 | 针对股价的差价合约 —— 仅取得价格敞口,并不拥有相关股份。 |
|---|---|
| 延长时段 | 在交易所常规时段以外的盘前及盘后交易。 |
| 基差风险 | 差价合约参考价与交易所成交价未必同步变动的风险。 |
| 市盈率 | 市盈率 = 股价 ÷ 每股盈利;常用的估值指标。 |
| 毛利率 | 毛利 ÷ 营收;反映产品层面的盈利能力。 |
| 每股盈利 | 每股盈利 = 净利润 ÷ 摊薄后流通股数。 |
Get Started with Novartis AG
Start trading Novartis AG on CoinUnited.io with industry-leading leverage and fees that drop to 0% at the top VIP tier.
Trade with Leverage
Trade NVS CFDs with up to 1000x leverage on CoinUnited.io.
- Up to 1000x leverage
- Fees down to 0%
- Advanced risk management tools
Explore Stocks
Browse the full stocks market on CoinUnited.io with 125+ instruments.
- 125+ stocks instruments
- Real-time market data
- Professional charting tools
Learn Stocks Trading
Read our in-depth research and analysis on stocks markets.
- Expert market analysis
- Technical analysis basics
- Daily market insights
How to Trade Novartis AG: Step-by-Step Guide
Learn how to trade Novartis AG (NVS) on CoinUnited.io with up to 1000x leverageand volume-tiered fees that reach 0% at the top VIP level. Follow this simple step-by-step guide to start CFD trading today.
Create Your CoinUnited.io Account
Sign up at CoinUnited.io in under a minute. You'll need an email address to get started.
- ✓Quick and free registration
- ✓Email and password setup
- ✓Two-factor authentication for security
Verify Your Identity
Complete the KYC verification process to unlock full trading features and higher limits.
- ✓Upload government-issued ID
- ✓Proof of address document
- ✓Usually verified within minutes
Deposit Funds
Fund your account using one of the supported deposit methods.
Deposit Methods
- •Cryptocurrency deposits (BTC, ETH, USDT)
- •Bank transfer available
- •No minimum deposit requirement
Find NVS in the Stocks Section
Navigate to the stocks market section and search for NVS. You can trade Novartis AG as a CFD with up to 1000x leverage.
- ✓Search for "NVS" in the trading platform
- ✓Select CFD trading mode
- ✓Review the current price and market data
Place Your Trade
Choose your position direction (long or short), set your leverage, and enter your position size to trade Novartis AG.
- ✓Long (buy) if you expect NVS to rise
- ✓Short (sell) if you expect NVS to fall
- ✓Set stop-loss and take-profit levels
Monitor & Manage Risk
Keep track of your open positions and manage risk with stop-loss orders and position sizing.
- ✓Monitor P&L in real-time
- ✓Adjust stop-loss as needed
- ✓Never risk more than you can afford to lose
Order Types
Market Order
Execute immediately at the current market price. Best for quick entries.
Limit Order
Set a specific price to enter. The order fills only when the market reaches your price.
Stop-Loss Order
Automatically close your position at a specified price to limit potential losses.
Important Tips
- • Start with a small position to understand how leverage works
- • Always set a stop-loss to protect your capital
- • Higher leverage amplifies both gains and losses
- • Never invest more than you can afford to lose
标签
Similar Stocks Assets
Explore other stocks instruments in the same sector as Novartis AG. Compare performance and find trading opportunities.

D-Wave Quantum Inc.
Snap Inc.
ProShares UltraShort Silver

TTM Technologies, Inc.

Chewy, Inc.
免责声明与参考资料
重要风险提示
CoinUnited 股票差价合约只提供 Novartis AG 的价格敞口,并非股权拥有:没有股东投票权、没有股息,亦不会以相关股票交收。
杠杆同时放大亏损与盈利,仓位可能在相关股价回升之前已被强制平仓。相关股票按交易所时段挂牌,参考价可能在时段之间跳空。
用户在做出任何投资决策前,应自行进行充分研究,并咨询具有专业资质的金融顾问。平台开发方与运营方不对因依赖所提供信息而造成的任何财务损失或其他后果承担责任。
杠杆交易风险极高,可能损失全部本金。
方法论概览
本页数据来自一手及具名第三方来源,并非由预测模型产生。每一项的来源与日期均列于上方的出处对照表。
- 财务报表:公司自身的 SEC 申报文件(10-K/10-Q),由 XBRL 读取
- 市场数据:CoinUnited 参考价及每日收市价
- 机构持股:SEC Form 13F 季度申报
- 分析师目标价:聚合的第三方卖方研究 — 属第三方意见,并非 CoinUnited 观点
- 同业倍数:第三方过去十二个月比率
CoinUnited 不会就 Novartis AG 发布价格预测或目标价。
上次方法论审阅时间:



